⚖UPC-Intel
🇪🇺 UPC

UPC_CoA_528/2024

Court
Court of Appeal (Luxembourg)
Type of action
procedural
Patent
ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
Language
en
Claimant / applicant
  • Regeneron Pharmaceuticals Inc.
  • SANOFI-AVENTIS GROUPE S.A.
  • SANOFI-AVENTIS DEUTSCHLAND GMBH
  • SANOFI WINTHROP INDUSTRIE S.A.
Defendant / respondent
  • AMGEN, INC, One Amgen Center Drive
  • AMGEN, INC

Track this case

Get an email when a new order or decision is published in UPC_CoA_528/2024.

Decisions and documents (2)

Weekly digest

A weekly email summarising new published decisions across European patent courts.